Revium Rx (RVRC) Net Shares Issued and Repurchased (2024 - 2025)
Revium Rx's (RVRC) quarterly Net Shares Issued and Repurchased came in at $690000.0 in Q4 2025, down 6.76% year-over-year from $740000.0 in Q4 2024, and down 6.76% quarter-over-quarter from $740000.0 in Q4 2024.
Powered by 
Analysis
Revium Rx (RVRC) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Net Shares Issued and Repurchased across 2 years of filings, most recently posting $690000.0 for Q4 2025.
- In Q4 2025, Net Shares Issued and Repurchased fell 6.76% year-over-year to $690000.0; the TTM figure through Dec 2025 stood at $690000.0 (down 6.76% YoY), while the FY2025 annual figure was $690000.0, down 6.76% from the prior year.
- Net Shares Issued and Repurchased came in at $690000.0 for Q4 2025 at Revium Rx, down from $740000.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $740000.0 in Q4 2024 to a low of $690000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Revium Rx | 86.84 Mn | 85.34 Mn | - | - |